Company / PP&E per Share
aTYR PHARMA INC PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.05
FY2025
5-year range
$0.05 / $0.19
FY2021-FY2025
Trend
-33.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.19 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -26.2%.
Declined from $0.19 to $0.05 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -22.8%
- 5-Year CAGR
- -26.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 33.8% year-over-year.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -33.8% |
| FY2024 | $0.08 | -59.1% |
| FY2023 | $0.19 | +70.4% |
| FY2022 | $0.11 | +123.3% |
| FY2021 | $0.05 | -78.7% |
| FY2020 | $0.23 | -60.2% |
| FY2019 | $0.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026